YMR247W-A Antibody

What is the YMR247W-A antibody and what organism does it target?

The YMR247W-A antibody is a rabbit-derived polyclonal antibody specifically designed to detect the Saccharomyces cerevisiae protein YMR247W-A. This protein is encoded by the gene YMR247W-A and remains functionally uncharacterized, though the antibody is widely utilized in yeast research for antigen detection and analysis. The antibody specifically targets S. cerevisiae strain S288c, which serves as the reference genome for this model organism. As a polyclonal preparation, it recognizes multiple epitopes on the YMR247W-A protein, enhancing detection sensitivity across various experimental platforms.

What are the key molecular properties of the YMR247W-A protein and antibody?

The YMR247W-A protein has a molecular weight of 5,152 Da and is identified by NCBI Gene ID 1466506 and UniProt Accession Q3E782. The corresponding polyclonal antibody belongs to the IgG isotype class and demonstrates specific reactivity against Saccharomyces cerevisiae strain S288c. The antibody preparation typically achieves >90% purity following affinity chromatography using protein A/G Sepharose. This high purity level ensures reliable experimental outcomes by minimizing non-specific binding and background signals in detection assays.

What validated research applications exist for the YMR247W-A antibody?

The YMR247W-A antibody has been validated for two primary research applications:

These validated applications enable researchers to investigate YMR247W-A expression patterns and quantify protein levels in experimental conditions, despite the protein's unknown function. Researchers should note that optimization of antibody concentration is essential for each application to achieve optimal signal-to-noise ratios.

How is the YMR247W-A antibody produced and formulated?

The YMR247W-A antibody is produced using recombinant YMR247W-A protein expressed in either E. coli or yeast expression systems as the immunogen. Following rabbit immunization, the antibody undergoes purification via affinity chromatography using protein A/G Sepharose, achieving >90% purity. The final product is supplied in liquid form with 50% glycerol and 0.01M PBS (pH 7.4), preserved with 0.03% Proclin 300. This formulation ensures antibody stability during storage and maintains immunoreactivity over extended periods when stored according to manufacturer recommendations.

How can I validate the specificity of YMR247W-A antibody in my experimental system?

Validating antibody specificity is crucial, particularly for studying uncharacterized proteins like YMR247W-A. A comprehensive validation approach includes:

• Genetic Control Analysis: Utilize YMR247W-A knockout strains as negative controls in Western blot and immunoprecipitation experiments. The absence of signal in these strains confirms specificity.

• Peptide Competition Assay: Pre-incubate the antibody with excess recombinant YMR247W-A protein before application in your detection method. Signal reduction or elimination indicates specificity.

• Cross-Reactivity Assessment: Test the antibody against related yeast homologs to determine potential cross-reactivity patterns. This is particularly important when studying proteins with high sequence similarity.

• Multiple Detection Methods: Confirm consistency across different detection platforms (e.g., Western blot, ELISA, and immunofluorescence if applicable) to strengthen confidence in specificity.

Antibody validation should be conducted under the same experimental conditions planned for your research to ensure relevance of the validation results.

What strategies can I employ to optimize Western blot detection of YMR247W-A protein?

Optimizing Western blot protocols for the low molecular weight (5,152 Da) YMR247W-A protein requires specific technical considerations:

• Gel Selection: Use high-percentage (15-20%) polyacrylamide gels or specialized tricine-SDS-PAGE systems designed for low molecular weight proteins.

• Transfer Optimization: Employ semi-dry transfer with methanol-containing buffers at lower voltage (10-12V) for extended periods (1-2 hours) to prevent small protein loss.

• Membrane Selection: PVDF membranes with 0.2 μm pore size (rather than standard 0.45 μm) improve retention of small proteins.

• Blocking Optimization: Use 5% non-fat dry milk or 3% BSA in TBS-T with brief (30-minute) blocking to prevent epitope masking of small proteins.

• Antibody Titration: Perform serial dilutions (typically 1:500 to 1:5000) to determine optimal antibody concentration that maximizes specific signal while minimizing background.

• Enhanced Chemiluminescence: Use high-sensitivity ECL substrates with extended exposure times if signal intensity is weak due to low expression levels.

These optimizations account for the challenging nature of detecting small yeast proteins while maximizing signal specificity and intensity.

What approaches can address the functional characterization of the uncharacterized YMR247W-A protein?

Despite lacking functional annotation, several strategies can leverage the YMR247W-A antibody to elucidate protein function:

• Co-Immunoprecipitation (Co-IP): Use the antibody to pull down YMR247W-A and identify interacting proteins through mass spectrometry. Interacting partners often share functional relationships.

• Chromatin Immunoprecipitation (ChIP): If nuclear localization is suspected, ChIP can determine whether YMR247W-A associates with specific genomic regions.

• Subcellular Localization: Combine the antibody with cell fractionation or immunofluorescence techniques to determine YMR247W-A's cellular compartmentalization.

• Expression Profiling: Quantify YMR247W-A expression under various stress conditions or growth phases to identify conditions that modulate its expression.

• CRISPR/Cas9 Deletion Analysis: Create knockout strains and assess phenotypic changes across multiple conditions, using the antibody to confirm deletion.

• Interactome Profiling: Combine with systems biology approaches to place YMR247W-A within broader protein interaction networks.

These complementary approaches can collectively provide insights into YMR247W-A function through its associations, localizations, and expression patterns.

How should I prepare yeast samples for optimal YMR247W-A detection?

Effective yeast protein extraction is critical for successful YMR247W-A detection:

Regardless of method, including protease inhibitors is essential as small proteins like YMR247W-A are particularly susceptible to degradation. Samples should be processed quickly and kept cold throughout preparation. For Western blot applications, loading higher protein amounts (30-50 μg) may be necessary due to potentially low expression levels of YMR247W-A.

What are the common technical challenges in YMR247W-A antibody applications and how can they be addressed?

Several technical challenges may arise when working with the YMR247W-A antibody:

• Weak Signal Detection:

  • Challenge: Low endogenous expression levels of YMR247W-A

  • Solution: Increase antibody concentration, extend incubation time to overnight at 4°C, employ signal amplification systems, or use concentrated samples from larger culture volumes

• High Background:

  • Challenge: Non-specific binding in polyclonal antibody preparations

  • Solution: Increase blocking agent concentration to 5%, extend blocking time to 2 hours, increase wash durations and numbers, or pre-adsorb antibody with non-target proteins

• Cross-Reactivity:

  • Challenge: Potential recognition of related yeast proteins

  • Solution: Include knockout controls, perform peptide competition assays, or use more stringent washing conditions

• Protein Degradation:

  • Challenge: Small proteins are susceptible to proteolysis

  • Solution: Use fresh samples, include multiple protease inhibitors, maintain cold temperatures throughout processing, and add phosphatase inhibitors if phosphorylation is relevant

• Antibody Stability Issues:

  • Challenge: Activity loss during storage

  • Solution: Aliquot upon receipt, avoid freeze-thaw cycles, store in recommended buffer conditions with 50% glycerol at -20°C

Addressing these challenges requires systematic optimization and appropriate controls to ensure reliable experimental outcomes.

How can I quantitatively analyze YMR247W-A expression under different experimental conditions?

Quantitative analysis of YMR247W-A expression requires rigorous methodological approaches:

• Western Blot Densitometry:

  • Load equal protein amounts confirmed by total protein staining (Ponceau S)

  • Include internal loading controls (e.g., housekeeping proteins like PGK1 or TDH3)

  • Use digital imaging systems with linear dynamic range

  • Analyze band intensity using software like ImageJ with background subtraction

  • Normalize to loading controls and present as fold-change relative to control conditions

• Quantitative ELISA:

  • Develop standard curves using recombinant YMR247W-A protein

  • Ensure samples fall within the linear range of detection

  • Run technical triplicates and biological replicates

  • Calculate concentration based on standard curve regression analysis

• Statistical Analysis:

  • Apply appropriate statistical tests based on experimental design

  • Consider non-parametric tests if normality cannot be confirmed

  • Report variability measures (standard deviation or standard error)

  • Establish significance thresholds (p < 0.05) for comparing conditions

These approaches enable robust quantification of YMR247W-A expression changes in response to experimental variables, providing insights into potential regulatory mechanisms despite its uncharacterized function.

What control experiments should I include when studying protein-protein interactions involving YMR247W-A?

When investigating protein-protein interactions involving YMR247W-A, include these critical controls:

• Input Controls: Analyze a small fraction of the pre-immunoprecipitation lysate to confirm target protein presence.

• Antibody Controls: Include:

  • Isotype control (non-specific rabbit IgG) to assess non-specific binding

  • No-antibody control to identify proteins binding to the isolation matrix

  • Pre-immune serum control if available

• Reciprocal Co-IP: Confirm interactions by immunoprecipitating with antibodies against putative interacting partners and probing for YMR247W-A.

• Genetic Controls:

  • Perform parallel experiments in YMR247W-A deletion strains

  • Use strains with tagged versions of YMR247W-A for confirmation with anti-tag antibodies

• Specificity Controls:

  • Include competition with excess recombinant YMR247W-A

  • Test interaction persistence under increasing salt concentrations to assess strength

• Technical Validation:

  • Confirm interactions using alternative methods (e.g., proximity ligation assay, yeast two-hybrid)

  • Examine interactions under different extraction conditions that preserve weak or transient associations

These controls collectively ensure that identified interactions are specific and biologically relevant rather than experimental artifacts.

How can I integrate YMR247W-A antibody data with systems biology approaches?

Integrating YMR247W-A antibody-derived data with systems biology approaches enhances functional insights through:

• Network Analysis Integration:

  • Map YMR247W-A interactions identified through immunoprecipitation-mass spectrometry onto existing protein interaction networks

  • Calculate network metrics (centrality, clustering) to predict functional importance

  • Identify membership in known protein complexes or functional modules

• Correlation with Transcriptomic Data:

  • Compare protein expression patterns (detected by the antibody) with mRNA expression profiles across conditions

  • Identify post-transcriptional regulation through discrepancies between protein and mRNA levels

  • Correlate with transcription factor binding sites near the YMR247W-A gene

• Computational Prediction Integration:

  • Compare experimental antibody-derived localization with computational predictions

  • Assess protein structural features (domains, motifs) for functional hints

  • Evaluate evolutionary conservation patterns across fungi to infer functional importance

• Multi-Omics Data Visualization:

  • Create integrated visualizations combining antibody-derived expression data with other omics datasets

  • Use dimension reduction techniques to identify condition clusters where YMR247W-A behavior is distinctive

  • Develop predictive models of YMR247W-A function based on integrated datasets

This systems-level integration contextualizes antibody-derived data within broader biological frameworks, generating testable hypotheses about YMR247W-A function.

What considerations should guide experimental design when studying post-translational modifications of YMR247W-A?

Investigating potential post-translational modifications (PTMs) of YMR247W-A requires specialized experimental design:

• Sample Preparation Adaptations:

  • Include phosphatase inhibitors (sodium orthovanadate, sodium fluoride) for phosphorylation studies

  • Add deacetylase inhibitors (trichostatin A, nicotinamide) for acetylation studies

  • Include proteasome inhibitors (MG132) for ubiquitination analysis

  • Maintain cold temperatures throughout to preserve labile modifications

• Detection Strategy Selection:

  • Use modification-specific antibodies in combination with YMR247W-A antibody

  • Employ Phos-tag gels for mobility shift detection of phosphorylated forms

  • Consider two-dimensional gel electrophoresis to separate modified isoforms

  • Apply mass spectrometry for precise modification site identification

• Control Treatments:

  • Include treatment with specific modifying enzymes (phosphatases, deacetylases)

  • Compare wild-type with strains lacking suspected modifying enzymes

  • Examine modification status across growth phases and stress conditions

• Functional Impact Assessment:

  • Generate modification site mutants (phospho-mimetic/phospho-dead)

  • Examine effects on localization, interactions, or stability

  • Monitor modification dynamics during cellular responses

These considerations enable robust characterization of YMR247W-A PTMs, potentially revealing regulatory mechanisms despite the protein's uncharacterized function.

How should contradictory data regarding YMR247W-A expression or localization be reconciled?

When faced with contradictory experimental results regarding YMR247W-A:

• Methodological Evaluation:

  • Assess differences in sample preparation techniques (extraction methods, buffer compositions)

  • Compare antibody concentrations, incubation conditions, and detection systems

  • Evaluate cell growth conditions, strain backgrounds, and experimental timing

  • Consider technical limitations of each approach (resolution, sensitivity, specificity)

• Biological Interpretation:

  • Investigate condition-dependent expression or localization patterns

  • Consider cell cycle-dependent changes in protein behavior

  • Examine potential isoform expression or alternative processing

  • Assess contributions of strain-specific genetic backgrounds

• Validation Through Orthogonal Methods:

  • Confirm antibody-based results with epitope-tagged versions of YMR247W-A

  • Correlate protein detection with transcript levels through RT-qPCR

  • Employ multiple microscopy techniques for localization studies

  • Use different antibody clones or epitope targets if available

• Data Integration Framework:

  • Develop models accommodating apparently contradictory observations

  • Consider dynamic processes rather than static states

  • Evaluate threshold effects or population heterogeneity contributions

  • Quantify variability to distinguish biological variation from technical artifacts

This systematic approach transforms contradictory data from a limitation into an opportunity for deeper biological insights into YMR247W-A behavior.

What emerging technologies might enhance future YMR247W-A antibody applications?

Several emerging technologies could significantly advance YMR247W-A research:

• Proximity Labeling Approaches: BioID or APEX2 fusions with YMR247W-A could map its proximal proteome, revealing transient interactions and microenvironment composition.

• Super-Resolution Microscopy: Techniques like STORM or PALM could provide nanoscale resolution of YMR247W-A localization beyond conventional microscopy limits.

• Single-Cell Proteomics: Emerging methods for single-cell protein quantification could reveal cell-to-cell variability in YMR247W-A expression previously masked in population averages.

• Live-Cell Antibody Derivatives: Development of nanobodies or scFv fragments derived from the YMR247W-A antibody could enable live-cell imaging of dynamic processes.

• Spatial Transcriptomics Integration: Correlating spatial protein distribution with transcriptional landscapes could provide functional context for localization patterns.

These technologies would complement traditional antibody applications while addressing current methodological limitations in studying this uncharacterized protein.

How can researchers contribute to building a more comprehensive understanding of YMR247W-A function?

Advancing YMR247W-A functional characterization requires a community approach:

• Standardized Reporting: Document detailed methodological parameters when publishing YMR247W-A antibody-based results, including:

  • Antibody dilutions and incubation conditions

  • Extraction methods and buffer compositions

  • Strain background genetic details

  • Growth conditions and cell cycle stage

• Resource Development:

  • Generate and share tagged strains and knockout collections

  • Create antibodies against different epitopes for validation

  • Develop condition-specific expression datasets

• Interdisciplinary Integration:

  • Combine genetic, biochemical, and computational approaches

  • Apply evolutionary analysis across fungal species

  • Utilize comparative proteomics between related organisms

• Data Sharing:

  • Contribute raw data to repositories beyond published findings

  • Document negative results to prevent duplication of effort

  • Share optimized protocols through community platforms

This collaborative framework accelerates functional discovery beyond what individual research groups could achieve in isolation for challenging uncharacterized proteins like YMR247W-A.

What are the broader implications of studying uncharacterized proteins like YMR247W-A?

Research on uncharacterized proteins like YMR247W-A has far-reaching implications:

• Fundamental Knowledge Expansion: Even well-studied organisms like S. cerevisiae contain proteins of unknown function, highlighting significant gaps in our understanding of core biological processes.

• Methodological Advancement: The challenges of studying uncharacterized proteins drive development of improved research tools and approaches applicable across biological research.

• Systems Biology Enhancement: Complete understanding of cellular networks requires characterization of all components, including currently uncharacterized nodes like YMR247W-A.

• Evolutionary Insights: Uncharacterized proteins often represent novel adaptations or specialized functions that illuminate evolutionary processes.

• Translational Potential: Previously uncharacterized proteins frequently emerge as therapeutic targets or biomarkers once their functions are elucidated.